Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 EUR | 0.00% | -6.75% | -43.70% |
Apr. 05 | Vitura Health JV Commences Manufacture of GMP LaNeo MDMA; Shares Up 3% | MT |
Mar. 18 | Vitura Health Joint Venture Supplies First Psilocybin for Patient Use Outside Trial | MT |
Sales 2021 | 72.56M 77.28M | Sales 2022 | 72.78M 77.52M | Capitalization | 416M 443M |
---|---|---|---|---|---|
Net income 2021 | 36M 38.34M | Net income 2022 | -4M -4.26M | EV / Sales 2021 | 18.9 x |
Net Debt 2021 | 776M 826M | Net Debt 2022 | 820M 874M | EV / Sales 2022 | 17 x |
P/E ratio 2021 |
16.1
x | P/E ratio 2022 |
-97.6
x | Employees | 3 |
Yield 2021 |
3.51% | Yield 2022 |
0.86% | Free-Float | 41.58% |
1 week | -6.75% | ||
Current month | -13.64% | ||
1 month | -22.84% | ||
3 months | -43.70% | ||
6 months | -45.71% | ||
Current year | -43.70% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 15-11-04 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 16-04-13 | |
Jean-Marc Besson
BRD | Director/Board Member | - | 16-04-13 |
Director/Board Member | 54 | 16-02-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 7.6 | 0.00% | 1 |
24-04-18 | 7.6 | -3.18% | 56 |
24-04-17 | 7.85 | 0.00% | 1 |
24-04-16 | 7.85 | -2.48% | 133 |
24-04-15 | 8.05 | -1.23% | 4 |
Real-time Euronext Paris, April 19, 2024 at 03:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-43.70% | 138M | |
-14.59% | 9.22B | |
-2.62% | 6.6B | |
-8.07% | 4.95B | |
-8.56% | 4.93B | |
-4.10% | 4.18B | |
+12.43% | 4.13B | |
-17.27% | 3.83B | |
-17.18% | 3.03B | |
-0.90% | 3.01B |
- Stock Market
- Equities
- VTR Stock